Objective There have been concerns about the long term safety of paclitaxel coated devices
in the lower limbs. A formal systematic review and meta-analysis of randomised controlled …

Aims Optimal endovascular management of intermittent claudication (IC) remains disputed.
This systematic review and meta-analysis compares efficacy and safety outcomes for …

Background The results of a recent meta-analysis aroused concern about an increased risk
of death associated with the use of paclitaxel-coated angioplasty balloons and stents in …

Background: A clear patency benefit of a drug-eluting stent (DES) over bare metal stents
(BMSs) for treating peripheral artery disease of the femoropopliteal segment has not been …

Aims The first reports of declining hospital admissions for major cardiovascular emergencies
during the COVID-19 pandemic attracted public attention. However, systematic evidence on …

Aims Cardiac resynchronization therapy (CRT) is an established treatment for heart failure.
There is contradictory evidence whether defibrillator capability improves prognosis in …

Background Numerous randomised clinical trials and real-world studies have supported the
safety of paclitaxel-coated devices for the treatment of femoropopliteal occlusive disease …

Objectives This study sought to evaluate the safety and effectiveness of the Ranger drug-
coated balloon (DCB)(paclitaxel dose density 2 μg/mm2) for treating superficial femoral …

Objective Optimal pharmacological treatment (OPT) for peripheral arterial occlusive disease
(PAOD) includes prescription of lipid lowering drugs, antithrombotics, and antihypertensives …

Background: Previous observational studies reported a wide variation and possible room for
improvement in the treatment of patients suffering from symptomatic peripheral artery …